Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

Autor: Shin, Junghoon1 (AUTHOR), Park, Sehhoon1 (AUTHOR), Kim, Kyung Hwan2,3 (AUTHOR), Shin, Eui-Cheol3 (AUTHOR), Jung, Hyun Ae1 (AUTHOR), Cho, Jong Ho4 (AUTHOR), Sun, Jong-Mu1 (AUTHOR), Lee, Se-Hoon1 (AUTHOR), Choi, Yong Soo4 (AUTHOR), Ahn, Jin Seok1 (AUTHOR), Kim, Jhingook4 (AUTHOR), Park, Keunchil1 (AUTHOR), Shim, Young Mog4 (AUTHOR), Kim, Hong Kwan4 (AUTHOR), Noh, Jae Myoung5 (AUTHOR), Ahn, Yong Chan5 (AUTHOR), Pyo, Hongryull5 (AUTHOR), Ahn, Myung-Ju1 (AUTHOR) silkahn@skku.edu
Zdroj: Cancer Research & Treatment. Oct2024, Vol. 56 Issue 4, p1084-1095. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje